v3.25.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net loss $ (2,017,553) $ (1,903,794)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 431 431
Stock-based compensation 300,288 335,417
Changes in operating assets and liabilities:    
Prepaid expenses (168,529) (486,714)
Accounts payable (225,400) 50,886
Accrued expenses 312,638 102,140
Net cash used in operating activities (1,798,125) (1,901,634)
Cash flows from investing activities:    
Purchases of property and equipment
Net cash used in investing activities
Cash flows from financing activities:    
Proceeds from issuance of common stock and warrants, net of issuance costs 5,674,651
Proceeds from warrant exercises 105,816
Proceeds from short term insurance financing 181,797 561,885
Payments on short term insurance financing (17,727) (54,731)
Net cash provided by financing activities 164,070 6,287,621
Net (decrease) increase in cash and cash equivalents (1,634,055) 4,385,987
Cash and cash equivalents, beginning of period 5,435,983 2,624,730
Cash and cash equivalents, end of period 3,801,928 7,010,717
Supplemental cash flow information:    
Cash paid for interest 1,015 3,273
Cash paid for taxes

Source